The relationship between anatomical location of phaeochromocytoma and paraganglioma and their secretory properties

Thong Chung Lim, Bernard Khoo(University College London), Karim Meeran(Imperial College London), Martyn Caplin(The Royal Free Hospital), Waljit S. Dhillo(Imperial College Healthcare NHS Trust), Jasdeep Gill, Jeannie F Todd(Bradford Teaching Hospitals NHS Foundation Trust), Fausto Palazzo(Hammersmith Hospital), Susan E Brook, Tricia Tan, Pierre Bouloux, Niamh Martin(Hammersmith Hospital), Radha Ramachandran(Hammersmith Hospital)

Endocrine Abstracts

March 1, 2013

10.1530/endoabs.31.p159

Cited by 0

Related Papers

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

|New England Journal of Medicine|2017|3.2k

Gastroenteropancreatic neuroendocrine tumours

|The Lancet Oncology|2008|1.8k

Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes

|JAMA|2018|406

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <sup>177</sup>Lu-Dotatate in the Phase III NETTER-1 Trial

|Journal of Clinical Oncology|2018|388

Somatic mutation of CDKN1B in small intestine neuroendocrine tumors

|Nature Genetics|2013|374